dimenhydrinate Syrup 8 mg, 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20412
A pharmaceutical manufacturer producing a diverse range of pharmaceutical products covering multiple therapeutic segments, including tablets, capsules, syrups and other formulations. The company highlights operations in both domestic and global markets, supported by certified GMP-compliant manufacturing facilities and quality systems such as ISO 9001:2015, to ensure consistent safety, efficacy and reliability in the production of its pharmaceutical products.
Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection. Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.